Schizophrenia

• 1/17/2025

  Revolutionizing Alzheimer’s: The Billion-Dollar Breakthrough

• 1/16/2025

  Johnson & Johnson Boosts Neuro Treatment Portfolio with $14.6B Deal

• 11/15/2024

  AbbVie’s Schizophrenia Treatment Fails: What’s Next?

• 11/13/2024

  AbbVie’s Schizophrenia Drug Fails, Bristol Myers Squibb Gains Edge

• 10/2/2024

  **Neurocrine Biosciences Play**

• 9/28/2024

  **FDA Approves Groundbreaking Schizophrenia Treatment**